Amgen wanted to raise physician's awareness of IL-1 prior to their release of
Kineret (http://www.kineretrx.com), which addressed the issues
of Interleukin and its role in treating rheumatoid arthritis.
To create an informative resource and provide research to both novice and experienced physicians on Interleukin.
UX accomplished all of the above and helped launch www.interleukin-1.com,
which provided physicians with detailed data, including Power
Point presentations, scientific meeting schedules, rheumatology
milestones, a tracking mechanism for research findings, and
a host of links to credible resources for further information.
IL-1 served as the preliminary resource template for future